Petros Pharmaceuticals IncNASDAQ:PTPI
- LAST PRICE1.4000
- TODAY'S CHANGE (%)-0.1365 (-8.8838%)
- Bid / Lots1.4000/ 1
- Ask / Lots1.8800/ 1
- Open / Previous Close1.7200 / 1.5365
- Day Range
- 52 Week Range
- Volume3,572
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PTPI |
|---|---|---|
| 10:51 ET | 130 | 1.72 |
| 11:02 ET | 123 | 1.68 |
| 01:24 ET | 129 | 1.62 |
| 02:18 ET | 200 | 1.57 |
| 03:21 ET | 813 | 1.36 |
| 03:36 ET | 100 | 1.41 |
| 03:52 ET | 100 | 1.435 |
| 03:54 ET | 212 | 1.4 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Petros Pharmaceuticals Inc | 3.2M | -0.9x | --- |
Epigenomics AG | 3.3M | 0.0x | --- |
NovaBay Pharmaceuticals Inc | 2.8M | -0.3x | --- |
International Stem Cell Corp | 1.5M | -2.2x | --- |
Catalyst Biosciences Inc | 7.6M | 0.6x | --- |
Bellicum Pharmaceuticals Inc | 2.5M | -0.6x | --- |
Company Information
Petros Pharmaceuticals, Inc. is a pharmaceutical company focused on men's health therapeutics with a range of commercial capabilities including sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. The Company is also focused on identifying, developing, acquiring, and commercializing therapeutics for men's health issues, including, erectile dysfunction (ED), endothelial dysfunction, psychosexual and psychosocial ailments, peyronie's disease, hormone health, and substance use disorders. The Company also markets its own line of ED products in the form of vacuum erection device (VED) products through its subsidiaries, Timm Medical, Inc. In addition, its ED products, the Company is focused on identifying and developing other pharmaceuticals to advance men's health, which is H100, which is the topical formulation candidate for the treatment of acute peyronie's disease.
Contact Information
- Headquarters
- 1185 Avenue Of The Americas 3Rd Floor, Suite 570NEW YORK, NY, United States 10036
- Phone
- 973-242-0005
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- John Shulman
- President, Chief Commercial Officer
- Fady Boctor
- Independent Vice Chairman of the Board
- Joshua Silverman
- Chief Accounting Officer, Vice President - Finance
- Mitchell Arnold
- Independent Director
- Bruce Bernstein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2M |
|---|---|
Revenue (TTM) | $4.3M |
Shares Outstanding | 2.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.51 |
Book Value | $1.72 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -549.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
